We wish to characterize the mechanisms for responsible for focal segmental glomerulosclerosis (FSGS) and use these findings to devise more effective therapy; we are particularly interested in HIV-associated FSGS. We have hypothesized that HIV accessory proteins (Vpr, Vpu, and Vif) mediate renal injury, leading to the histologic pattern of focal segmental glomerulosclerosis. We have established transgenic lines in with the endothelin-1 promoter (ET) drives Vpu or Vif. ET-vpu mice have a lung phenotype, in which the bronchioles and arterioles have perivascular cuffing (composed predominantly of macrophages) and macrophage pneumonitis characterized by macrophages within the alveoli. Endothelial cells, the presumed site of transgene expression, show activation markers, including increased expression of ICAM-1. Endothelial cells have been shown to be infected with HIV-1 in vitro and in vivo. Thus these findings suggest that the accessory protein Vpu may activate endothelial cells to promote leukocyte entry into tissues. We have collected blood and prepared immortalized B cell lines as a source of DNA from approximately 123 African-American patients with FSGS and a control group 193 African Americans infected with HIV but without renal disease, with the help of collaborators from eight medical centers around the country. We have initiated candidate gene analysis and have examined renin, angiogensin converting enzyme, kallikrein, and the Duffy antigen without finding a disease linkage. We plan to begin a random genome scan within the next year

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK043308-03
Application #
6105460
Study Section
Special Emphasis Panel (MDB)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Heymann, Jurgen; Winkler, Cheryl A; Hoek, Maarten et al. (2017) Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte. Nephrol Dial Transplant 32:i65-i70
Okamoto, Koji; Honda, Kenjiro; Doi, Kent et al. (2015) Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney. Am J Pathol 185:1889-98
Lee, Hewang; Abe, Yoshifusa; Lee, Icksoo et al. (2014) Increased mitochondrial activity in renal proximal tubule cells from young spontaneously hypertensive rats. Kidney Int 85:561-9
Cravedi, P; Kopp, J B; Remuzzi, G (2013) Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant 13:266-74
Abe, Yoshifusa; Sakairi, Toru; Beeson, Craig et al. (2013) TGF-?1 stimulates mitochondrial oxidative phosphorylation and generation of reactive oxygen species in cultured mouse podocytes, mediated in part by the mTOR pathway. Am J Physiol Renal Physiol 305:F1477-90
Sharma, Kumar; Ix, Joachim H; Mathew, Anna V et al. (2011) Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 22:1144-51
Wong, Yuen Fei; Kopp, Jeffrey B; Roberts, Catherine et al. (2011) Endogenous retinoic acid activity in principal cells and intercalated cells of mouse collecting duct system. PLoS One 6:e16770
Kopp, Jeffrey B; Winkler, Cheryl A; Nelson, George W (2010) MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Semin Nephrol 30:409-17
Genovese, Giulio; Friedman, David J; Ross, Michael D et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841-5
Oleksyk, Taras K; Nelson, George W; An, Ping et al. (2010) Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One 5:e11474

Showing the most recent 10 out of 77 publications